Le Lézard
Classified in: Science and technology, Business
Subjects: NPT, PDT

Dynex Unveils Dynex Moonshots, Dedicated to Transformative Change Through Capital-Enhanced n.quantum Computing


Global Thought Leaders Join Dynex Moonshots' Ethical Committee, Strengthening Commitment to Ethical Integrity and Innovation

VADUZ, Liechtenstein, April 2, 2024 /PRNewswire/ -- Dynex, the world's only accessible neuromorphic quantum computing cloud for solving real-world problems at scale, proudly announces the launch of Dynex Moonshots, the investment, strategic, and ethical steward of the Dynex Ecosystem. Leveraging the endless innovative advancements made possible by Dynex n.quantum computing, Dynex Moonshots accelerates the global movement of transformative change for the betterment of our world and beyond.

Dynex

Through global collaboration, a robust ethical framework, and access to capital, Dynex Moonshots is poised to transform industries and drive positive change on a global scale. Dynex Moonshots focuses on the advancement of society, nature, health, and space, and is open to any established business, research initiative or emerging ventures in need of harnessing the unparalleled capabilities of the Dynex n.quantum computing cloud, applying its power to confirm hypotheses swiftly and reducing time constraints. To apply for consideration, visit dynexmoonshots.org.

The work of Dynex Moonshots will be informed by its Ethical Committee, which is tasked with overseeing the ethical integrity of select Dynex n.quantum computing inquiries. The Ethical Committee's role is critical to ensuring that activities under the purview of Dynex Moonshots adhere to the highest ethical standards and contribute positively to the future.

The Ethical Committee includes:

"Dynex Moonshots represents a new frontier in ethical innovation, where cutting-edge technology meets unwavering ethical principles," said Daniela Herrmann, Co-Founder of Dynex and Mission Leader, Dynex Moonshots. "Through collaboration, integrity, and vision, Dynex Moonshots is poised to redefine what is possible and leave a lasting impact on the world and beyond."

For more information, please visit dynexmoonshots.org.

About Dynex:            
Dynex is the world's only accessible neuromorphic computing cloud for solving real-world problems, at scale. The company began as an informal project with collaboration amongst a community of extraordinary minds and quickly evolved into a technological leader ready to scale into global markets. The Dynex n.quantum computing cloud performs quantum computing based algorithms without limitation, executing calculations with unparalleled speed and efficiency, surpassing usual quantum computing constraints. Dynex is dedicated to pushing the boundaries of technology to create sustainable, secure, and innovative solutions that address complex challenges and drive progress, solving real world problems.

Press Contact:
[email protected]

Logo - https://mma.prnewswire.com/media/2376715/Transparent__Dynex_Logo.jpg


These press releases may also interest you

at 03:40
HTA Group, Ltd (the "Offeror"), an indirect wholly owned subsidiary of Helios Towers plc (the "Company"), announces the launch of its offer to purchase for cash any and all of the 7.000% Senior...

at 03:20
In a grand ceremony held on Wednesday in the Russian Embassy in Beijing, two sculptures portraying the renowned Russian novelist Maxim Gorky (1868-1936) and his Chinese counterpart Lu Xun (1881-1936), who was the most influential representative of...

at 03:15
Cresilon Inc. ("Cresilon"), a Brooklyn-based biotechnology company focused on haemostatic medical device technologies, today announced it has entered into a distribution agreement for its revolutionary haemostatic gel, VETIGEL®, to be sold directly...

at 03:00
KnowBe4, the provider of the world's largest security awareness training and simulated phishing platform, today released its report on cyber threats faced by the financial sector in the UK. The report examines the escalating rise of cyberattacks on...

at 02:46
OKX, a leading Web3 technology company, has issued updates for May 20, 2024. OKX DEX Incorporates ChangeNOW's Cross-Chain Bridges:...

at 02:07
GC Biopharma (006280. KS) and Novel Pharma announced that its jointly developed MPS IIIA 'GC1130A' treatment has received FDA IND approval....



News published on and distributed by: